DOI 10.1007/s00216-013-6969-z
ORIGINAL PAPER
Received: 24 October 2012 / Revised: 13 March 2013 / Accepted: 3 April 2013 / Published online: 9 May 2013
# Springer-Verlag Berlin Heidelberg 2013
Abstract Mulitpotent mesenchymal stem cells (MSCs) derived from human bone marrow are promising candidates for
the development of cell therapeutic strategies. MSC surface
protein profiles provide novel biological knowledge
concerning the proliferation and differentiation of these cells,
Electronic supplementary material The online version of this article
(doi:10.1007/s00216-013-6969-z) contains supplementary material,
which is available to authorized users.
S. K. Lee : J. H. Kim : T. Kang : N. H. Park : K.-H. Kwon :
K. Cho : S. Y. Yun : J. Y. Han : J. S. Yoo : Y. M. Park
Mass Spectrometry Research Center, Korea Basic Science Institute,
Ochang 363-887, Republic of Korea
S.-S. Kim : H. young Suh-Kim
Department of Anatomy, Ajou University, School of Medicine,
Suwon 443-749, Republic of Korea
T. Kang : N. H. Park : S. Y. Yun : J. S. Yoo : H. J. An
Graduate Schools of Analytical Science and Technology,
Chungnam National University,
Daejeon 305-764, Republic of Korea
S. S. Lee : Z. W. Lee : Y. M. Park
Biotechnology Fusion Research Team, Korea Basic Science
Institute, Daejeon 305-333, Republic of Korea
Y. M. Park (*)
Mass Spectrometry Research Center, Korea Basic Science Institute,
Ochang 363-883, Republic of Korea
e-mail: ympark@kbsi.re.kr
Present Address:
S. K. Lee
Eulji Medical and Biological Research Institute (EMBRI),
Daejeon 302-799, Republic of Korea
Present Address:
S. S. Lee
Department of Biology, Chungnam National University,
Daejeon 305-764, Republic of Korea
5502
(MSCs) [1]. MSCs exhibit multipotent differentiation potential, allowing differentiation into a variety of mesodermal
cell types such as osteoblasts, chondrocytes, adipocytes, skeletal muscle cells, and smooth muscle cells [25]. MSCs are
also capable of differentiating into cells of nonmesodermal
origin, such as hepatocytes, glial cells, and neurons [68].
Human MSCs (hMSCs) have been isolated from bone
marrow, periosteum, trabecular bone, adipose tissue,
synovium, skeletal muscle, and deciduous teeth [9]. Several
methods can be used to isolate MSCs on the basis of their
physical and physicochemical characteristics, such as adherence to plastic or other extracellular matrix components. Owing to the ease of isolation and their extensive differentiation
potential, MSCs have clinical potential [10, 11]. The
multipotent differentiation potential of adult MSCs, their capability of growth and differentiation in culture media, and
their highly reduced immunoreactivity after allogenic transfer
make the cells ideal cells for tissue repair and regeneration in
clinical cell therapy applications, including regenerative medicine, cell-based therapy, and tissue engineering [1215].
However, this potential is currently hampered by several
drawbacks associated with bone marrow, which is the
source of MSCs. The drawbacks include high susceptibility
to viral exposure, the necessity of invasive procedures for
marrow collection, the rarity of MSCs in the marrow, and
the age-related significant decrease in cell number, cell
proliferative capacity, and cell differentiation capacity.
Thus, ex vivo expansion of MSCs is necessary prior to their
being used in clinical applications [1618].
Despite these challenges, autologous MSCs may be free
from the complications associated with immune rejection and
teratocarcinoma formation, and their use avoids the ethical
concerns that cloud the use of embryonic stem cells [19].
Fibroblast growth factors (FGFs) are a group of cytokines
that play major regulatory roles in development, wound
healing, hematopoiesis, and tumorigenesis [2023]. To date,
at least 22 FGFs have been identified in vertebrate tissues.
Acidic FGF and basic FGF (bFGF), with molecular masses of
1819 kDa, are especially well characterized and are very
important in human tissues. These two FGFs modulate cellular functions via four distinct high-affinity membrane receptors with an intrinsic tyrosine kinase activity [23]. The FGF
receptor (FGFR) family also consists of four receptor tyrosine
kinases designated FGFR1, FGFR2, FGFR3, and FGFR4
[24]. The acidic FGF and bFGF prototypical members of the
FGF family of growth factors are able to bind FGFR1 and
FGFR2, leading to receptor dimerization/oligomerization, activation of intrinsic receptor tyrosine kinase activity, and the
phosphorylation of specific tyrosine residues in the cytoplasmic tail of the receptor [25]. It was recently reported that bFGF
affects the long-term in vitro expansion of multipotent humanspinal-cord-derived neurospheres in the presence of epidermal
growth factor and ciliary neurotrophic factor [26].
Methods
Materials
SDS-PAGE gels were obtained from Sigma-Aldrich (St. Louis,
MO, USA). Sequencing-grade-modified trypsin was obtained
from Promega (Madison, WI, USA). C18 (Aqua, 5 m) column resins were purchased from Phenomenex (Torrance, CA,
USA). Silica capillary tips (20 cm, inner diameter 75 m; tip
inner diameter 8 m) were obtained from Proxeon (Odense,
Denmark).
Cell culture
MSCs were isolated from human bone marrow aspirate as
described previously [41]. Cells were cultured in
Dulbeccos modified Eagles medium containing 10 % fetal
bovine serum, 100 U penicillin, and 100 mg/mL streptomycin (Invitrogen, Carlsbad, CA, USA), and, in some
experiments, 10 ng/mL bFGF (Dong-A Pharmaceutical,
Youngin, Republic of Korea). To determine the potential
of MSCs to differentiate into adipocytes, osteocytes, and
chondrocytes, differentiation was induced as described
previously [5].
Surface protein isolation
Biotinylation of hMSCs with EZ-link sulfo-NHS-SS-biotin
(Pierce, Rockford, IL, USA) was performed according to the
manufacturers instructions. The hMSCs were grown to 90
95 % confluence in 150-mm-diameter tissue culture plates, the
medium was removed, and the cells were washed twice with
phosphate-buffered saline (PBS). Ten milliliters of PBS
containing 0.25 mg/mL EZ-link sulfo-NHS-SS-biotin was
added to cover the cells, which were incubated at 4 C for
30 min on a rocking platform. The biotinylation reaction was
terminated by addition of 500 L of quenching solution.
Following biotinylation, the cells were harvested by centrifugation (500 g, 3 min) and washed two times with
tris(hydroxymethyl)aminomethane-buffered saline (TBS).
Cells were solubilized in 500 L of lysis buffer (Pierce)
containing mammalian protease inhibitor cocktail (Roche,
Mannheim, Germany). The cells were further disrupted by
brief sonication and incubation for 30 min on ice, with
vortexing every 5 min for 5 s. Solubilized biotinylated membrane proteins were collected by centrifugation at 10,000g for
2 min at 4 C. Clarified supernatant containing biotinylated
membrane proteins was incubated with 500 L of immobilized
NeutrAvidin gel slurry (Pierce), which was prewashed with
wash buffer (Pierce), for 60 min at room temperature with endover-end mixing using a rotator. After incubation with
NeutrAvidin, the surface proteins were eluted from the column
with elution buffer, which was a mixture of 7 M urea, 2 M
thiourea, and 4 % 3-[(3-cholamidopropyl)dimethylammonio]1-propanesulfonate containing a final concentration of 50 mM
dithiothreitol (DTT). For two-dimensional electrophoresis
analysis, through three independent experiments and surface
proteins were normalized using the Bradford protein assay
(Bio-Rad, Hercules, CA, USA).
5503
5504
Results
Multipotency of MSCs
To investigate the effects of bFGF on differentiation potential,
hMSCs were cultured with growth medium supplemented
with or without bFGF for six or seven passages, respectively.
Adipogenic, osteogenic, or chondrogenic differentiation was
induced individually for 3 weeks. When undifferentiated
MSCs were incubated in the absence of bFGF, they assumed
an increased spread-out and myoblast-like morphology. When
MSCs were cultured with bFGF, they displayed a consistent
spindle-shape and elongated form (data not shown). When
MSCs were cultured with bFGF, the cells were able to differentiate into adipocytes, osteocytes, and chondrocytes. In the
absence of bFGF, these cells were unable to differentiate into
adipocytes. However, the cells still retained the potential to
differentiate into osteocytes and chondrocytes. The results
suggest that bFGF maintains multipotency of MSCs during
culture expansion in vitro.
Surface protein isolation of the hMSCs
The primary aim of this study was to identify and quantify
changes in surface proteins in hMSCs cultured with or without
bFGF. We first enriched surface proteins and membraneassociated proteins using the membrane-impermeable reagent
sulfo-NHS-SS-biotin and separated the proteins using
multidimensional separation strategies [45, 46]. Enriched surface proteins were isolated by biotinavidin interaction,
followed by one-dimensional SDS-PAGE and then digested
by trypsin. Tryptic fragments were separated by reverse-phase
LC prior to characterization by MS/MS. Figure 1 summarizes
this process. To confirm the efficiency of the surface protein
isolation method, the gene list of isolated proteins was submitted to the Database for Annotation, Visualization, and
Integrated Discovery (DAVID, version 6.7, http://david.abcc.
ncifcrf.gov/) [47]. The isolated surface proteins and membrane associated proteins were recovered with recovery rate
of 82.1 % (p<1.6010-120). A list of membrane proteins is
provided in Table S3.
To examine the difference in proteome profiling between
MSCs cultured with or without bFGF, protein samples from
each culture were analyzed by one-dimensional SDS-PAGE
(Fig. 2). Total protein amounts were measured based on equal
5505
loading amounts of protein (100 ug) in each lane. The observed bands were sliced into 20 bands for each lane, with a
total 40 bands.
ESI-MS/MS analysis of tryptic fragments and data analysis
To develop a reliable proteome identification procedure, we
applied the reversed sequence database to Mascot and selected the high-score peptide sequences with an error rate of
less than 5 %. After MS/MS spectra had been analyzed
using these methods, we were able to identify proteins from
the three independent trials. A list of proteins quantified in
the present study containing detailed exponentially modified
protein abundance index (emPAI) information of the peptides acquired by MS/MS is presented in Table S1.
We identified 1,001 proteins by gathering 857 and 667
proteins from MSCs cultured with and without bFGF, respectively (Fig. 3). Among the 857 proteins identified from MSCs
cultured with bFGF, 179 proteins overlapped among the three
trials. Only 122, 257, and 91 proteins were identified uniquely
in the first, second, and third trials, respectively. Of the 667
proteins identified from MSCs cultured without bFGF, 116
proteins overlapped between the three trials. Only 70, 282,
and 48 proteins were identified uniquely in the first, second,
and third trials, respectively (Fig. 4).
To compare the proteome of MSCs cultured with and
without bFGF-containing medium, the 334 and 144 unique
proteins uniquely identified in the two conditions were classified using FatiGO. As shown in Fig. 5, the unique proteins
were classified and compared by their cellular components,
biological processes, and molecular functions. Consequently,
we found a difference in cellular components, molecular
5506
For the quantitative analysis, the protein abundance was estimated and compared by the emPAI. This quantification index
is based on the number of sequenced peptides per protein and
is directly proportional to protein content (mol %) [48]. This
index was directly calculated by the Mascot research server.
The difference in the protein content (mol %) in the absence of
bFGF and in the presence of bFGF was calculated, and the
ratio of the averaged emPAI was obtained in two different
grades (Fig. 6). If a protein displayed a higher emPAI value
in the presence of bFGF in all three trials, we classified that
protein as grade 2. If a protein displayed a higher emPAI value
in the presence of bFGF in only two trials, we classified the
protein as grade 1. For proteins expressed more in the absence
of bFGF, we defined grade 1 and grade 2 similarly. If the
protein was identified more in the absence of bFGF in the three
trials, it was classified as grade 2. Grade 1 was reserved for
proteins having a higher emPAI value in the absence of bFGF
in two of the trials. Accordingly, we classified 365 identified
proteins (Table S2). The protein content (mol %) listed was
normalized to the number of total counts estimating the relative
amount of the different proteins within the sample.
Functional classification of identified proteins using Gene
Ontology
Fig. 3 Venn diagram of overlapping proteins between the two different medium conditions. A total of 1,001 unique proteins were identified from the three independent trials. MSC mesenchymal stem cell
5507
Fig. 5 Comparison of unique MSC proteins according to the cellular component (a), molecular function (b), and biological process (c)
5508
Fig. 5 (continued)
Discussion
MSCs are considered to be suitable candidates for cell-based
therapy owing to their intrinsic capacity to self-renew and
5509
Digestion
Response to abiotic stimulus
Antigen processing and presentation
Reproductive process
Developmental growth
MSC - bFGF
Cytokine production
Aging
Gene
Protein name
IPI00293464
IPI00293533
IPI00003479
IPI00219097
IPI00219037
IPI00304596
IPI00020127
DDB1
NUP62
MAPK1
HMGB2
H2AFX
NONO
RPA1
IPI00018195
IPI00005154
IPI00015947
IPI00555565
IPI00012535
IPI00220578
IPI00018274
IPI00220642
IPI00216319
IPI00414442
MAPK3
SSRP1
DNAJB1
HSP90AB4P
DNAJA1
GNAI3
EGFR
YWHAG
YWHAH
CDK5RAP3
IPI00008380
PPP2CA
IPI00005668
IPI00029733
IPI00180954
IPI00004656
AKR1C2
AKR1C1
CIRBP
B2M
IPI00020021
IPI00456429
DEK
UBA52
Protein DEK
Ubiquitin and ribosomal protein L40 precursor
IPI00410488
IPI00549248
CD276
NPM1
surface proteins in hMSCs cultured with or without bFGFcontaining medium by two-dimensional gel electrophoresis
[52]. To examine the comprehensive expression pattern of
the surface proteome in hMSCs, we performed semiquantitative analysis and identified 1,001 unique proteins in hMSCs.
This study also demonstrates the utility of a multidimensional
protein profiling strategy for comprehensive profiling of MSC
surface proteomes. We performed surface protein isolation and
one-dimensional electrophoresis to reduce protein complexity,
and used nanoscale LC/ESI-MS/MS for analysis of tryptic fragments. We analyzed the wide range of proteomes for the hMSCs
using multidimensional protein prefractionation methods, such
as cell surface protein isolation, one-dimensional electrophoresis,
and reverse-phase LC, as it was the most effective method to
identify a large number of proteins [54, 55].
Several signal transduction pathways can be activated by
FGFRs, some of which are implicated in bFGF-induced
5510
presence of bFGF for CAV1 (a), RPSA (b), Rab11b (c), YWHAG (d),
YWHAQ (e), and YWHAB (f)
5511
Table 2 Proteins related to the membrane, cell differentiation, and signal transduction among the proteins which have grade 1 or or grade 1 or
more
Gene
Annotations
Grade
Classification
Gene
Annotations
Grade
Classification
ACAA2
ANPEP
ANXA1
ANXA2
ANXA5
ARCN1
ARF4
IPI00001539
IPI00221224
IPI00218918
IPI00418169
IPI00329801
IPI00298520
IPI00215918
2
2
2
2
2
2
2
M
S, M
S, D, M
M
S, D
M
D, M
LRRC59
MAPK1
MMP14
MRC2
NME1
PHB
PLEC1
1
1
1
1
1
1
1
M
S, D
M
M
S
S, D, M
M
ARPC2
IPI00005161
ATP5B
ATP5O
BZW1
IPI00303476
IPI00007611
IPI00180128, IPI00785096
2
2
2
M
M
S
PLOD2
PLXNB2
PPP2R1A
IPI00396321
IPI00003479
IPI00218398
IPI00005707
IPI00012048
IPI00017334
IPI00398776, IPI00398775,
IPI00186711
IPI00014898, IPI00398779,
IPI00398002
IPI00337495
IPI00853369, IPI00852623
IPI00554737
1
1
1
M
S, M
S, D, M
CACNA2D1
PRDX2
IPI00027350
CAP1
CD109
CD44
COPE
DCBLD2
DPYSL2
ENG
GNAI2
GPD2
HADHA
IPI00953650, IPI00953262,
IPI00470535
IPI00939159, IPI00008274
IPI00152540,
IPI00297160
IPI00465132, IPI00399319
IPI00419836
IPI00257508
IPI00017567
IPI00926935, IPI00748145
IPI00017895, IPI00719611
IPI00031522,
2
2
2
2
2
2
2
2
2
2
D, M
M
M
M
D, M
S, D
D, M
D
M
M
PRDX4
PSMC5
PTRF
RAB10
RAB11B
RPN1
RPN2
RPSA
SEC23A
SEPT7
IPI00011937
IPI00745502, IPI00023919
IPI00514023
IPI00016513
IPI00020436
IPI00025874
IPI00028635
IPI00411639, IPI00413108
IPI00017375
IPI00033025, IPI00941534
1
1
1
1
1
1
1
1
1
1
D
S
M
D, M
D, M
M
M
D, M
M
S
HIST1H4L
IPI00453473,
S, D
SEPT9
S, M
HSP90AA1
ITGA2
KCTD12
KPNB1
LGALS1
LGALS3
MSN
NT5E
P4HB
IPI00382470
IPI00013744
IPI00060715
IPI00001639
IPI00219219
IPI00465431
IPI00219365, IPI00872814
IPI00009456
IPI00010796
2
2
2
2
2
2
2
2
2
D
D, M
M
S, M
S, D
M
M
M
M
SET
SPTBN1
SQRDL
SSR1
SSR4
STAT1
TGM2
THY1
TLN1
IPI00784808, IPI00784614,
IPI00455033
IPI00072377
IPI00005614, IPI00333015
IPI00009634
IPI00301021
IPI00019385
IPI00030781
IPI00294578
IPI00022892
IPI00298994
1
1
1
1
1
1
1
1
1
S
M
M
M
M
S, D
D, M
S, D, M
S, M
PDIA3
RAB1B
RAB5C
RAB7A
RDX
SERPINE2
SPTAN1
TXNDC5
VCP
YWHAE
YWHAG
YWHAQ
YWHAZ
IPI00893541, IPI00025252
IPI00008964
IPI00016339
IPI00016342
IPI00017367, IPI00903145
IPI00914848, IPI00009890
IPI00843765
IPI00171438
IPI00022774
IPI00000816
IPI00220642
IPI00018146
IPI00021263
2
2
2
2
2
2
2
2
2
2
2
2
2
S, D
D, M
D
D
S, D, M
S
M
S
S, D
D
S, D
D
S, D
TMED10
TNPO1
TUBB2C
TWF2
TXNL1
UACA
VCL
VPS35
ZYX
ACTN1
DBN1
FLNA
FLNB
IPI00028055
IPI00024364
IPI00930130
IPI00550917
IPI00305692
IPI00173359
IPI00307162, IPI00291175
IPI00018931
IPI00926625
IPI00921118, IPI00013508
IPI00003406
IPI00302592
IPI00289334
1
1
1
1
1
1
1
1
1
2
2
2
2
M
S, M
S
M
S, D
S, M
S, M
M
D, M
S, M
S, M
D
S, D, M
5512
Table 2 (continued)
Gene
Annotations
Grade
Classification
Gene
Annotations
Grade
Classification
ACAT1
AKAP12
ALDH3A2
ARHGDIA
ATP5A1
ATP5C1
ATP6V1A
CALR
CAND1
CAPN2
CAPZA1
CAPZA2
IPI00030363
IPI00217683
IPI00333619
IPI00003815
IPI00440493
IPI00395769
IPI00007682
IPI00020599
IPI00100160
IPI00289758
IPI00005969
IPI00026182
1
1
1
1
1
1
1
1
1
1
1
1
M
D
M
S, D, M
M
M
M
S, M
S
S
S
S
LIMA1
ACTG1
ACTN4
ALCAM
ALPL
AP2B1
CANX
CAV1
CDH13
CDH2
CLTC
CNN2
IPI00796222, IPI00008918
IPI00021440
IPI00013808
IPI00015102
IPI00419916
IPI00790702, IPI00784156
IPI00020984
IPI00009236
IPI00024046
IPI00290085
IPI00024067
IPI00015262
2
1
1
1
1
1
1
1
1
1
1
1
M
S
S
D, M
M
S, M
M
S, D, M
M
M
M
M
CFL1
CKAP4
COMT
COPB1
COPZ1
IPI00012011
IPI00141318
IPI00011284
IPI00295851
IPI00032851
1
1
1
1
1
S, D
M
M
M
M
COL1A2
EEA1
EHD2
EMD
IPI00304962
IPI00329536
IPI00100980
IPI00032003
1
1
1
1
D
M
M
M
FN1
CRTAP
CTNNA1
CTNNB1
CTNND1
CTSB
CYB5R3
IPI00748502
IPI00215948
IPI00017292
IPI00182469, IPI00219725
IPI00295741
IPI00328415
1
1
1
1
1
1
D
S
S, D, M
D
S
M
HSPA9
HSPB1
IQGAP1
ITGA11
ITGA3
MYH9
IPI00339228, IPI00339224,
IPI00022418
IPI00007765
IPI00025512
IPI00009342
IPI00215613, IPI00941391
IPI00215995
IPI00395772, IPI00019502
1
1
1
1
1
1
S
S
D, M
D, M
S, D, M
S, D, M
DDOST
DDX1
DNAJA2
DNM1L
EEF1D
EHD1
EIF5A
ENPP1
EPHA2
GALNT1
IPI00297084
IPI00293655
IPI00032406
IPI00235412, IPI00037283
IPI00023048, IPI00642971
IPI00017184
IPI00376005
IPI00184311
IPI00021267
IPI00025818
1
1
1
1
1
1
1
1
1
1
M
S
M
M
D
M
S
M
D, M
M
MYO1C
NAPA
NPM1
PDGFRB
PLOD1
RPS14
RRBP1
SLC7A5
SPARC
VDAC1
IPI00743335, IPI00010418
IPI00009253
IPI00549248, IPI00220740
IPI00015902
IPI00027192
IPI00026271
IPI00215743
IPI00008986
IPI00014572
IPI00216308
1
1
1
1
1
1
1
1
1
1
M
S
S, D
D, M
M
S
D, M
M
D
S, D, M
GDI2
GLUD1
HSP90B1
HSPA1A
IPI00031461
IPI00016801
IPI00027230
IPI00304925, IPI00911039,
IPI00845339
IPI00003362
IPI00784154
IPI00743104
IPI00306604
IPI00027505, IPI00922108
IPI00217563
IPI00220327
IPI00217975
IPI00009771
1
1
1
1
D
D
S, M
S
VDAC2
IPI00216026, IPI00024145
1
1
1
1
1
1
1
1
1
S, D, M
S
S, D, M
S, D, M
D, M
D, M
M
M
M
HSPA5
HSPD1
ITGA1
ITGA5
ITGAV
ITGB1
KRT1
LMNB1
LMNB2
Fig. 7 Validation of proteins identified by one-dimensional SDSPAGE coupled with mass spectrometry. a Western blotting analysis
of CAV1 and RPSA. b Confocal immunofluorescence analysis of
THY1 and RAB11B. The scale bar denotes 20 m
5513
5514
Conclusions
In this study, we identified a total of 1,001 proteins in hMSCs.
To increase the confidence in the proteins identified, we used a
reversed sequence database and strict criteria such as multiple
hit proteins and grades. This work has shown that a combination of technologies is required for reducing sample complexity. We also provide evidence of different surface proteins and
surface-protein-associated proteins in MSCs cultured in a
medium with or without bFGF. Some proteins such as laminin
and Ras-related Rab proteins are related to bFGF-induced
signal transduction of MSCs. Consequently, our results also
provide insight into the understanding of the surface proteome
of hMSCs.
Acknowledgments This work was supported by grants to Y.M.P.
from the Korea Institute of Science & Technology Evaluation and
Planning (20062004605) and from the Korea Basic Science Institute
(G30124).
Study approval The Institutional Review Board of Ajou University
Medical Center (Suwon, Republic of Korea) approved this study.
Competing interests
References
1. Prockop DJ (1997) Marrow stromal cells as stem cells for
nonhematopoietic tissues. Science 276:7174
2. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD,
Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M et
al (2002) Pluripotency of mesenchymal stem cells derived from
adult marrow. Nature 418:4149
3. Krause DS (2002) Plasticity of marrow-derived stem cells. Gene
Ther 9:754758
4. Phinney DG, Kopen G, Isaacson RL, Prockop DJ (1999) Plastic
adherent stromal cells from the bone marrow of commonly used
strains of inbred mice: variations in yield, growth, and differentiation. J Cell Biochem 72:570585
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R,
Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR
(1999) Multilineage potential of adult human mesenchymal stem
cells. Science 284:143147
6. Brazelton TR, Rossi FM, Keshet GI, Blau HM (2000) From
marrow to brain: expression of neuronal phenotypes in adult
mice. Science 290:17751779
7. Hermann A, Gastl R, Liebau S, Popa MO, Fiedler J, Boehm BO,
Maisel M, Lerche H, Schwarz J, Brenner R, Storch A (2004)
Efficient generation of neural stem cell-like cells from adult
human bone marrow stromal cells. J Cell Sci 117:44114422
8. Woodbury D, Schwarz EJ, Prockop DJ, Black IB (2000) Adult rat
and human bone marrow stromal cells differentiate into neurons.
J Neurosci Res 61:364370
9. Barry FP, Murphy JM (2004) Mesenchymal stem cells: clinical
applications and biological characterization. Int J Biochem Cell
Biol 36:568584
10. Beyaert R, Fiers W (1994) Molecular mechanisms of tumor
necrosis factor-induced cytotoxicity. What we do understand
and what we do not. FEBS Lett 340:916
11. Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells
modulate allogeneic immune cell responses. Blood 105:18151822
12. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall
RY, Muul L, Hofmann T (2002) Isolated allogeneic bone
marrow-derived mesenchymal cells engraft and stimulate growth
in children with osteogenesis imperfecta: implications for cell
therapy of bone. Proc Natl Acad Sci USA 99:89328937
13. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL,
Neel M, Sussman M, Orchard P, Marx JC, Pyeritz RE, Brenner
MK (1999) Transplantability and therapeutic effects of bone
marrow-derived mesenchymal cells in children with osteogenesis
imperfecta. Nat Med 5:309313
14. Koc ON, Day J, Nieder M, Gerson SL, Lazarus HM, Krivit W
(2002) Allogeneic mesenchymal stem cell infusion for treatment
of metachromatic leukodystrophy (MLD) and Hurler syndrome
(MPS-IH). Bone Marrow Transplant 30:215222
15. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM,
Mukhachev V, Lavroukov A, Kon E, Marcacci M (2001) Repair
of large bone defects with the use of autologous bone marrow
stromal cells. N Engl J Med 344:385386
16. Amos TA, Gordon MY (1995) Sources of human hematopoietic
stem cells for transplantation a review. Cell Transplant 4:547
569
17. Mueller SM, Glowacki J (2001) Age-related decline in the osteogenic potential of human bone marrow cells cultured in threedimensional collagen sponges. J Cell Biochem 82:583590
5515
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
5516
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
5517
100. Aumailley M, Bruckner-Tuderman L, Carter WG, Deutzmann R,
Edgar D, Ekblom P, Engel J, Engvall E, Hohenester E, Jones JC
et al (2005) A simplified laminin nomenclature. Matrix Biol
24:326332
101. Ekblom P, Lonai P, Talts JF (2003) Expression and biological role
of laminin-1. Matrix Biol 22:3547
102. Kibbey MC, Grant DS, Kleinman HK (1992) Role of the SIKVAV
site of laminin in promotion of angiogenesis and tumor growth: an
in vivo Matrigel model. J Natl Cancer Inst 84:16331638
103. Kleinman HK, Weeks BS, Schnaper HW, Kibbey MC,
Yamamura K, Grant DS (1993) The laminins: a family of basement membrane glycoproteins important in cell differentiation
and tumor metastases. Vitam Horm 47:161186
104. Nurcombe V (1992) Laminin in neural development. Pharmacol
Ther 56:247264
105. Li X, Chen Y, Scheele S, Arman E, Haffner-Krausz R, Ekblom P,
Lonai P (2001) Fibroblast growth factor signaling and basement
membrane assembly are connected during epithelial morphogenesis of the embryoid body. J Cell Biol 153:811822